Ergosterol limits osteoarthritis development and progression through activation of Nrf2 signaling

Volume: 21, Issue: 3
Published: Jan 8, 2021
Abstract
Osteoarthritis (OA) is a common joint disorder characterized by progressive articular cartilage degeneration and destruction and results in gradual disability among middle‑aged and elderly patients. Our previous study demonstrated that depletion of nuclear factor erythroid 2‑related factor 2 (Nrf2) exacerbated cartilage erosion in an OA model and that activation of the Nrf2 pathway could counter this process. As a downstream target of Nrf2, heme...
Paper Details
Title
Ergosterol limits osteoarthritis development and progression through activation of Nrf2 signaling
Published Date
Jan 8, 2021
Volume
21
Issue
3
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.